2020 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2019 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2018 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2020 | 0 | 10.162.904 | 604.989 | 1 | ||
2019 | 0 | 3.429.217 | 203.750 | 1 | ||
2018 | 0 | 60.596.927 | 515.031 | 2 |
Total number of partners: 75
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 72
Frequent / Rare Partner Ratio: 0.04
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2020-01-01 | FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA | FAIR | participant | 10.162.904 | 15 |
2019-07-01 | Antibiotic Distribution and Recovery in Tissue | AB-DiRecT | participant | 3.429.217 | 6 |
2018-06-01 | Autism Innovative Medicine Studies – 2 – Trials | AIMS-2-TRIALS | participant | 54.999.999 | 48 |
2018-01-01 | Safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS) | TUDCA-ALS | participant | 5.596.928 | 10 |